Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 90162

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 06, 2022
Product types
Drug
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Noven Pharmaceuticals Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3

D-0889-2022
Recall number
D-0889-2022
Initiated
May 06, 2022
Classification
Class II
Status
Ongoing
Recalling firm
Noven Pharmaceuticals Inc
Quantity
274, 110 patches

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Defective Delivery System: customer complaints exceeded respective action limits.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective Delivery System: customer complaints exceeded respective action limits.

Code information

Lot: 90764 Exp. 08/2022

Distribution pattern

Nationwide to the U.S. Market